Clinical Trial Update: A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Reolysin in patients with metastatic breast cancer has completed recruitment and data collection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• REOLYSIN (pelareorep)

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED